John Wiley & Sons ( JW . A ): FQ2 EPS of $0.84. Revenue of $449M (+8% Y/Y). ( PR ) Post your comment!
Good morning and welcome to the Wiley's Second Quarter Earnings Call. As a reminder, this conference is being recorded. At this time, I would like to introduce Wiley's Director of Investor Relations, Mr. Brian Campbell. Please go ahead, Sir.
funding environment in the U.S. and Europe continues to face headwinds. We view the top-tier journal companies like Reed Elsevier and John Wiley & Sons JW . A as gaining market share in an overall pie with limited growth at the present time.
compared with older real estate and declining traffic and demographic patterns of many older department stores. John Wiley & Sons JW . A Wiley is an intriguing value play. There is negative market sentiment on Wiley because the company faces a decline in its college
John Wiley JW . A reported disappointing fourth-quarter results and fiscal 2014 earnings per share guidance of $2.85-$2.95, which was
John Wiley JW . A reported disappointing fourth-quarter results, and its flat fiscal 2014 earnings per share guidance of $2.85-$2.95 was
John Wiley & Sons JW . A named John Kritzmacher as chief financial officer, effective July 1, 2013. Kritzmacher will be responsible for all of Wiley
yielding returns on capital well above those of its peers, validating the company's wide economic moat. John Wiley & Sons JW . A | Fair Value Uncertainty: Medium | Market Cap: $2.3 Billion From the Premium Analyst Report : John Wiley & Sons' science
By Benjamin Wiley : Last August, Supap Kirtsaeng lost his appeal of a $600,000 judgment against him for legally buying 632 of Wiley's textbooks in Thailand, importing those books to the U.S., and selling them for $37,000, making around a 10% profit . Yesterday, the Supreme Court overturned that ...
shippers and carriers bestows a robust economic moat that should help protect economic profits for years to come. John Wiley & Sons JW . A | Fair Value Uncertainty: Medium From the Premium Analyst Report : John Wiley & Sons' science, technology, medical, and